{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:20:41Z","timestamp":1790799641859,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure (HF) is an increasingly important cause of morbidity and mortality in patients with autoimmune rheumatic diseases. Despite advances in cardiovascular prevention and treatment, HF incidence continues to rise in this population, driven by chronic systemic inflammation, immune-mediated myocardial injury, microvascular dysfunction, fibrosis, and treatment-related cardiotoxicity. Epidemiological studies consistently demonstrate a markedly increased HF risk across a broad spectrum of rheumatic diseases\u2014including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, idiopathic inflammatory myopathies, ankylosing spondylitis, and primary Sj\u00f6gren syndrome\u2014often manifesting at younger age and independently of traditional cardiovascular risk factors. Subclinical myocardial involvement is frequent and commonly precedes overt HF, with preserved ejection fraction representing the dominant phenotype, particularly in inflammatory arthritis and systemic sclerosis. Advances in speckle-tracking echocardiography, cardiac magnetic resonance, and circulating biomarkers such as natriuretic peptides and cardiac troponins have enabled earlier detection and refined risk stratification. Although anti-inflammatory therapies, including conventional and biologic disease-modifying antirheumatic drugs, may mitigate HF risk, optimal control of traditional cardiovascular risk factors and cautious use of cardiotoxic agents remain essential.<\/jats:p>","DOI":"10.1007\/s00296-026-06101-8","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:46:10Z","timestamp":1774496770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Heart failure in autoimmune rheumatic diseases"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-1191","authenticated-orcid":false,"given":"Yuliya","family":"Fedorchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-791X","authenticated-orcid":false,"given":"Mykhailo","family":"Fedorchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1229-2042","authenticated-orcid":false,"given":"Bekzhan A.","family":"Permenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-8002","authenticated-orcid":false,"given":"Burhan Fatih","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"6101_CR1","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/cfr.2023.05","volume":"9","author":"B Shahim","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH (2023) Global public health burden of heart failure: an updated review. Card Fail Rev 9:e11. https:\/\/doi.org\/10.15420\/cfr.2023.05","journal-title":"Card Fail Rev"},{"key":"6101_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02740-2","author":"M Goertz","year":"2025","unstructured":"Goertz M, Schupp T, Dudda J, Weidner K, Lau F, Schmitt A, Abel N, Abumayyaleh M, Steffen HJ, Langer HF, Duerschmied D, Akin I, Behnes M (2025) Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-025-02740-2","journal-title":"Clin Res Cardiol"},{"key":"6101_CR3","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1002\/ehf2.12947","volume":"7","author":"Y Khalid","year":"2020","unstructured":"Khalid Y, Dasu N, Shah A, Brown K, Kaell A, Levine A, Dasu K, Raminfard A (2020) Incidence of congestive heart failure in rheumatoid arthritis: a review of literature and meta-regression analysis. ESC Heart Fail 7:3745\u20133753. https:\/\/doi.org\/10.1002\/ehf2.12947","journal-title":"ESC Heart Fail"},{"key":"6101_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/app15031590","volume":"15","author":"D Blachut","year":"2025","unstructured":"4, Blachut D, Mazurkiewicz M, Schulz M, Cie\u015bla J, Przywara-Chowaniec B, Tomasik A (2025) Update: heart failure in systemic lupus erythematosus. Appl Sci 15:1590. https:\/\/doi.org\/10.3390\/app15031590","journal-title":"Appl Sci"},{"key":"6101_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11906-024-01311-6","volume":"26","author":"M Barozet","year":"2024","unstructured":"Barozet M, Le Tilly O, Bejan-Angoulvant T, Fesler P, Roubille C (2024) Hypertension and cardiovascular outcomes in inflammatory and autoimmune diseases: a systematic review and meta-analysis. Curr Hypertens Rep 26:419\u2013429. https:\/\/doi.org\/10.1007\/s11906-024-01311-6","journal-title":"Curr Hypertens Rep"},{"key":"6101_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/1573403X16666201014144022","volume":"17","author":"G Fram","year":"2021","unstructured":"Fram G, Wang DD, Malette K, Villablanca P, Kang G, So K, Basir MB, Khan A, McKinnon JE, Zervos M, O\u2019Neill WW (2021) Cardiac complications attributed to hydroxychloroquine: a systematic review of the literature pre-COVID-19. Curr Cardiol Rev 17:319\u2013327. https:\/\/doi.org\/10.2174\/1573403X16666201014144022","journal-title":"Curr Cardiol Rev"},{"key":"6101_CR7","doi-asserted-by":"publisher","first-page":"e014661","DOI":"10.1161\/JAHA.119.014661","volume":"9","author":"MJ Ahlers","year":"2020","unstructured":"Ahlers MJ, Lowery BD, Farber-Eger E, Wang TJ, Bradham W, Ormseth MJ, Chung CP, Stein CM, Gupta DK (2020) Heart failure risk associated with rheumatoid arthritis-related chronic inflammation. J Am Heart Assoc 9:e014661. https:\/\/doi.org\/10.1161\/JAHA.119.014661","journal-title":"J Am Heart Assoc"},{"key":"6101_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.rdc.2022.08.002","volume":"49","author":"AA Zagouras","year":"2023","unstructured":"Zagouras AA, Tang WHW (2023) Myocardial involvement in systemic autoimmune rheumatic diseases. Rheum Dis Clin North Am 49:45\u201366. https:\/\/doi.org\/10.1016\/j.rdc.2022.08.002","journal-title":"Rheum Dis Clin North Am"},{"key":"6101_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12872-025-05033-8","volume":"25","author":"L Huang","year":"2025","unstructured":"Huang L, Wang X, Yuan Y, Wu A, Tang L, Huang C, Yu L, Lin Q (2025) Evaluation of subclinical myocardial involvement in systemic lupus erythematosus using multiparametric cardiac magnetic resonance imaging. BMC Cardiovasc Disord 25:597. https:\/\/doi.org\/10.1186\/s12872-025-05033-8","journal-title":"BMC Cardiovasc Disord"},{"key":"6101_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hfc.2013.10.003","volume":"10","author":"K Wright","year":"2014","unstructured":"Wright K, Crowson CS, Gabriel SE (2014) Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Fail Clin 10:339\u2013352. https:\/\/doi.org\/10.1016\/j.hfc.2013.10.003","journal-title":"Heart Fail Clin"},{"key":"6101_CR11","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s10067-023-06762-x","volume":"42","author":"AY Gasparyan","year":"2023","unstructured":"Gasparyan AY (2023) Cardiovascular manifestations and comorbidities in rheumatic diseases: perspectives on timely diagnosis, prevention, and treatment. Clin Rheumatol 42:2531\u20132533. https:\/\/doi.org\/10.1007\/s10067-023-06762-x","journal-title":"Clin Rheumatol"},{"key":"6101_CR12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"6101_CR13","doi-asserted-by":"publisher","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","volume":"94","author":"X Lu","year":"2021","unstructured":"Lu X, Wang Y, Zhang J, Pu D, Hu N, Luo J, An Q, He L (2021) Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis. Int Immunopharmacol 94:107466. https:\/\/doi.org\/10.1016\/j.intimp.2021.107466","journal-title":"Int Immunopharmacol"},{"key":"6101_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/heartjnl-2016-309561","volume":"103","author":"CH Kim","year":"2017","unstructured":"Kim CH, Al-Kindi SG, Jandali B, Askari AD, Zacharias M, Oliveira GH (2017) Incidence and risk of heart failure in systemic lupus erythematosus. Heart 103:227\u2013233. https:\/\/doi.org\/10.1136\/heartjnl-2016-309561","journal-title":"Heart"},{"key":"6101_CR15","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jacc.2021.02.029","volume":"77","author":"A Yafasova","year":"2021","unstructured":"Yafasova A, Fosb\u00f8l EL, Schou M, Baslund B, Faurschou M, Docherty KF, Jhund PS, McMurray JJV, Sun G, Kristensen SL, Torp-Pedersen C, K\u00f8ber L, Butt JH (2021) Long-term cardiovascular outcomes in systemic lupus erythematosus. J Am Coll Cardiol 77:1717\u20131727. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.029","journal-title":"J Am Coll Cardiol"},{"key":"6101_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.semarthrit.2020.03.019","volume":"50","author":"JC Chang","year":"2020","unstructured":"Chang JC, Xiao R, Knight AM, Kimmel SE, Mercer-Rosa LM, Weiss PF (2020) A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus. Semin Arthritis Rheum 50:527\u2013533. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.019","journal-title":"Semin Arthritis Rheum"},{"key":"6101_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.hrtlng.2022.01.003","volume":"52","author":"JJ Chapa","year":"2022","unstructured":"Chapa JJ, Ilonze OJ, Guglin ME, Rao RA (2022) Heart transplantation in systemic lupus erythematosus: a case report and meta-analysis. Heart Lung 52:174\u2013181. https:\/\/doi.org\/10.1016\/j.hrtlng.2022.01.003","journal-title":"Heart Lung"},{"key":"6101_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0961203317734922","volume":"27","author":"K Tselios","year":"2018","unstructured":"Tselios K, Deeb M, Gladman DD, Harvey P, Urowitz MB (2018) Antimalarial-induced cardiomyopathy: a systematic review of the literature. Lupus 27:591\u2013599. https:\/\/doi.org\/10.1177\/0961203317734922","journal-title":"Lupus"},{"key":"6101_CR19","doi-asserted-by":"publisher","first-page":"6173276","DOI":"10.1155\/2019\/6173276","volume":"2019","author":"RJ Durrance","year":"2019","unstructured":"Durrance RJ, Movahedian M, Haile W, Teller K, Pinsker R (2019) Systemic lupus erythematosus presenting as myopericarditis with acute heart failure: a case report and literature review. Case Rep Rheumatol 2019:6173276. https:\/\/doi.org\/10.1155\/2019\/6173276","journal-title":"Case Rep Rheumatol"},{"key":"6101_CR20","doi-asserted-by":"publisher","first-page":"1402010","DOI":"10.3389\/fmed.2024.1402010","volume":"11","author":"T Zhou","year":"2024","unstructured":"Zhou T, Pan J, Yan C, Yuan J, Song H, Han Y (2024) Unveiling shared biomarkers and therapeutic targets between systemic lupus erythematosus and heart failure through bioinformatics analysis. Front Med (Lausanne) 11:1402010. https:\/\/doi.org\/10.3389\/fmed.2024.1402010","journal-title":"Front Med (Lausanne)"},{"key":"6101_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.semarthrit.2019.06.005","volume":"49","author":"SK Chen","year":"2019","unstructured":"Chen SK, Barbhaiya M, Fischer MA, Guan H, Yoshida K, Feldman CH, Costenbader KH, Everett BM (2019) Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general Medicaid patients. Semin Arthritis Rheum 49:389\u2013395. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.005","journal-title":"Semin Arthritis Rheum"},{"key":"6101_CR22","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.3346\/jkms.2020.35.e139","volume":"35","author":"JY Choe","year":"2020","unstructured":"Choe JY, Lee SS, Kwak SG, Kim SK (2020) Anti-Sm antibody, damage index, and corticosteroid use are associated with cardiac involvement in systemic lupus erythematosus: data from a prospective registry study. J Korean Med Sci 35:e139. https:\/\/doi.org\/10.3346\/jkms.2020.35.e139","journal-title":"J Korean Med Sci"},{"key":"6101_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s43044-024-00511-4","volume":"76","author":"N Akiash","year":"2024","unstructured":"Akiash N, Abbaspour S, Mowla K, Moradi A, Madjidi S, Sharifi P, Pazoki M (2024) Three-dimensional speckle tracking echocardiography for evaluation of ventricular function in patients with systemic lupus erythematosus: relationship between duration of lupus erythematosus and left ventricular dysfunction by using global longitudinal strain. Egypt Heart J 76:79. https:\/\/doi.org\/10.1186\/s43044-024-00511-4","journal-title":"Egypt Heart J"},{"key":"6101_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s10067-024-06929-0","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yin S, Lin Z, Zhao C, Zhang H (2024) Two-dimensional speckle-tracking echocardiography in left ventricular systolic function in patients with systemic lupus erythematosus. Clin Rheumatol 43:1871\u20131880. https:\/\/doi.org\/10.1007\/s10067-024-06929-0","journal-title":"Clin Rheumatol"},{"key":"6101_CR25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10554-020-01816-6","volume":"36","author":"W Deng","year":"2020","unstructured":"Deng W, Xie M, Lv Q, Li Y, Fang L, Wang J (2020) Early left ventricular remodeling and subclinical cardiac dysfunction in systemic lupus erythematosus: a three-dimensional speckle tracking study. Int J Cardiovasc Imaging 36:1227\u20131235. https:\/\/doi.org\/10.1007\/s10554-020-01816-6","journal-title":"Int J Cardiovasc Imaging"},{"key":"6101_CR26","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s10554-021-02201-7","volume":"37","author":"C Li","year":"2021","unstructured":"Li C, Li K, Yuan M, Bai W, Rao L (2021) Peak strain dispersion within the left ventricle detected by two-dimensional speckle tracking in patients with uncomplicated systemic lupus erythematosus. Int J Cardiovasc Imaging 37:2197\u20132205. https:\/\/doi.org\/10.1007\/s10554-021-02201-7","journal-title":"Int J Cardiovasc Imaging"},{"key":"6101_CR27","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/echo.15189","volume":"38","author":"J Feng","year":"2021","unstructured":"Feng J, Zhai Z, Wang Z, Huang L, Dong S, Liu K, Shi W, Lu G, Qin W (2021) Speckle tracking imaging combined with myocardial comprehensive index to evaluate left ventricular function changes in patients with systemic lupus erythematosus. Echocardiography 38:1632\u20131640. https:\/\/doi.org\/10.1111\/echo.15189","journal-title":"Echocardiography"},{"key":"6101_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejim.2019.12.033","volume":"73","author":"MND Di Minno","year":"2020","unstructured":"Di Minno MND, Forte F, Tufano A, Buonauro A, Rossi FW, De Paulis A, Galderisi M (2020) Speckle tracking echocardiography in patients with systemic lupus erythematosus: a meta-analysis. Eur J Intern Med 73:16\u201322. https:\/\/doi.org\/10.1016\/j.ejim.2019.12.033","journal-title":"Eur J Intern Med"},{"key":"6101_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.46497\/ArchRheumatol.2024.10131","volume":"39","author":"M Gegenava","year":"2024","unstructured":"Gegenava M, Kirtava Z, Kong WK, Gegenava T (2024) Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Arch Rheumatol 39:149\u2013158. https:\/\/doi.org\/10.46497\/ArchRheumatol.2024.10131","journal-title":"Arch Rheumatol"},{"key":"6101_CR30","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.26355\/eurrev_202204_28614","volume":"26","author":"X Ji","year":"2022","unstructured":"Ji X, Zhang X (2022) Assessment of left ventricular systolic synchrony by peak strain dispersion in patients with systemic lupus erythematosus. Eur Rev Med Pharmacol Sci 26:2840\u20132846. https:\/\/doi.org\/10.26355\/eurrev_202204_28614","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6101_CR31","doi-asserted-by":"publisher","unstructured":"Azpiri-Lopez JR, Galarza-Delgado DA, Garza-Cisneros AN, Guajardo-Jauregui N, Balderas-Palacios MA, Garcia-Heredia A, Cardenas-de la Garza JA, Rodriguez-Romero AB, Reyna-de la Garza RA, Azpiri-Diaz H, Alonso-Cepeda O, Colunga-Pedraza IJ (2022) Subclinical systolic dysfunction by speckle tracking echocardiography in patients with systemic lupus erythematosus. Lupus 31:1127\u20131131. https:\/\/doi.org\/10.1177\/09612033221106581","DOI":"10.1177\/09612033221106581"},{"key":"6101_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/14712598.2018.1462794","volume":"18","author":"M Baniaamam","year":"2018","unstructured":"Baniaamam M, Paulus WJ, Blanken AB, Nurmohamed MT (2018) The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review. Expert Opin Biol Ther 18:585\u2013594. https:\/\/doi.org\/10.1080\/14712598.2018.1462794","journal-title":"Expert Opin Biol Ther"},{"key":"6101_CR33","doi-asserted-by":"publisher","first-page":"e19658","DOI":"10.1097\/MD.0000000000019658","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang H, Li X, Gong G (2020) Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: a systematic review and meta-analysis. Med (Baltim) 99:e19658. https:\/\/doi.org\/10.1097\/MD.0000000000019658","journal-title":"Med (Baltim)"},{"key":"6101_CR34","doi-asserted-by":"publisher","first-page":"1377432","DOI":"10.3389\/fimmu.2024.1377432","volume":"15","author":"K Kadier","year":"2024","unstructured":"Kadier K, Dilixiati D, Zhang X, Li H, Kuang L, Huang J, Cai X, Ling T, Kong F, Liu X (2024) Rheumatoid arthritis increases the risk of heart failure: results from the cross-sectional study in the US population and mendelian randomization analysis in the European population. Front Immunol 15:1377432. https:\/\/doi.org\/10.3389\/fimmu.2024.1377432","journal-title":"Front Immunol"},{"key":"6101_CR35","doi-asserted-by":"publisher","first-page":"152816","DOI":"10.1016\/j.semarthrit.2025.152816","volume":"74","author":"TM Johnson","year":"2025","unstructured":"Johnson TM, Yang Y, Roul P, Frideres H, Baker JF, Sauer BC, Cannon GW, Kunkel GA, Bookani KR, Mikuls TR, England BR (2025) Risk and temporal trends of heart failure subtypes in rheumatoid arthritis. Semin Arthritis Rheum 74:152816. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152816","journal-title":"Semin Arthritis Rheum"},{"key":"6101_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ahj.2023.02.001","volume":"259","author":"J Fax\u00e9n","year":"2023","unstructured":"Fax\u00e9n J, Benson L, Mantel \u00c4, Savarese G, Hage C, Dahlstr\u00f6m U, Askling J, Lund LH, Andersson DC (2023) Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction. Am Heart J 259:42\u201351. https:\/\/doi.org\/10.1016\/j.ahj.2023.02.001","journal-title":"Am Heart J"},{"key":"6101_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/art.20855","volume":"52","author":"PJ Nicola","year":"2005","unstructured":"Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52:412\u2013420. https:\/\/doi.org\/10.1002\/art.20855","journal-title":"Arthritis Rheum"},{"key":"6101_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/acr.25481","volume":"77","author":"Y Kawano","year":"2025","unstructured":"Kawano Y, Weber BN, Weisenfeld D, Jeffway MI, Cai T, McDermott GC, Liu Q, Sparks JA, Stuart J, Joseph J, Cai T, Liao KP (2025) Risk of incident heart failure and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 77:631\u2013639. https:\/\/doi.org\/10.1002\/acr.25481","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6101_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acr.24804","volume":"75","author":"S Huang","year":"2023","unstructured":"Huang S, Cai T, Weber BN, He Z, Dahal KP, Hong C, Hou J, Seyok T, Cagan A, DiCarli MF, Joseph J, Kim SC, Solomon DH, Cai T, Liao KP (2023) Association between inflammation, incident heart failure, and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 75:1036\u20131045. https:\/\/doi.org\/10.1002\/acr.24804","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6101_CR40","doi-asserted-by":"publisher","first-page":"e007227","DOI":"10.1161\/JAHA.117.007227","volume":"7","author":"U Khalid","year":"2018","unstructured":"Khalid U, Egeberg A, Ahlehoff O, Lane D, Gislason GH, Lip GYH, Hansen PR (2018) Incident heart failure in patients with rheumatoid arthritis: a nationwide cohort study. J Am Heart Assoc 7:e007227. https:\/\/doi.org\/10.1161\/JAHA.117.007227","journal-title":"J Am Heart Assoc"},{"key":"6101_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/jpm14060615","volume":"14","author":"YS Kim","year":"2024","unstructured":"Kim YS, Hong JB, Kim H, Sheen SH, Han IB, Kim JG, Jeun SS, Sohn S (2024) The relationship between seropositive rheumatoid arthritis and congestive heart failure: a nationwide longitudinal cohort study in Korea. J Pers Med 14:615. https:\/\/doi.org\/10.3390\/jpm14060615","journal-title":"J Pers Med"},{"key":"6101_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/14740338.2018.1483331","volume":"17","author":"A Giollo","year":"2018","unstructured":"Giollo A, Bissell LA, Buch MH (2018) Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review. Expert Opin Drug Saf 17:697\u2013708. https:\/\/doi.org\/10.1080\/14740338.2018.1483331","journal-title":"Expert Opin Drug Saf"},{"key":"6101_CR43","doi-asserted-by":"publisher","first-page":"7712587","DOI":"10.1155\/2021\/7712587","volume":"2021","author":"S Hu","year":"2021","unstructured":"Hu S, Lin C, Cai X, Zhu X, Lv F, Nie L, Ji L (2021) The biological disease-modifying antirheumatic drugs and the risk of cardiovascular events: a systematic review and meta-analysis. Mediators Inflamm 2021:7712587. https:\/\/doi.org\/10.1155\/2021\/7712587","journal-title":"Mediators Inflamm"},{"key":"6101_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/joim.12715","volume":"284","author":"P Sarajlic","year":"2018","unstructured":"Sarajlic P, Frid\u00e9n C, Lund LH, Manouras A, Venkateshvaran A, Larsson SC, Nordgren B, Opava CH, Lundberg IE, B\u00e4ck M (2018) Enhanced ventricular-arterial coupling during a 2-year physical activity programme in patients with rheumatoid arthritis: a prospective substudy of the physical activity in rheumatoid arthritis 2010 trial. J Intern Med 284:664\u2013673. https:\/\/doi.org\/10.1111\/joim.12715","journal-title":"J Intern Med"},{"key":"6101_CR45","doi-asserted-by":"publisher","first-page":"e0253793","DOI":"10.1371\/journal.pone.0253793","volume":"16","author":"THP Nguyen","year":"2021","unstructured":"Nguyen THP, Fagerland MW, Deyab G, Hjeltnes G, Hollan I, Feinberg MW, Eilertsen G\u00d8, Mikkelsen K, Agewall S (2021) Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis. PLoS ONE 16:e0253793. https:\/\/doi.org\/10.1371\/journal.pone.0253793","journal-title":"PLoS ONE"},{"key":"6101_CR46","doi-asserted-by":"publisher","first-page":"1154271","DOI":"10.3389\/fendo.2023.1154271","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, Mei K, Chao C, Di D, Qian Y, Wang B, Zhang X (2023) Rheumatoid arthritis increases the risk of heart failure-current evidence from genome-wide association studies. Front Endocrinol (Lausanne) 14:1154271. https:\/\/doi.org\/10.3389\/fendo.2023.1154271","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6101_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5334\/gh.1256","volume":"18","author":"X Lin","year":"2023","unstructured":"Lin X, Zhou M, Zhang C, Li J (2023) Genetically determined rheumatoid arthritis may not affect heart failure: insights from Mendelian randomization study. Glob Heart 18:43. https:\/\/doi.org\/10.5334\/gh.1256","journal-title":"Glob Heart"},{"key":"6101_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1515\/rir-2024-0010","volume":"5","author":"V Batani","year":"2024","unstructured":"Batani V, Dagna L, De Luca G (2024) Therapeutic strategies for primary heart involvement in systemic sclerosis. Rheumatol Immunol Res 5:72\u201382. https:\/\/doi.org\/10.1515\/rir-2024-0010","journal-title":"Rheumatol Immunol Res"},{"key":"6101_CR49","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/jcm14072211","volume":"14","author":"MI Oliveira","year":"2025","unstructured":"Oliveira MI, Bragan\u00e7a B, Gomes JR, Santos M (2025) Cardiac involvement and heart failure staging in patients with systemic sclerosis without pulmonary arterial hypertension. J Clin Med 14:2211. https:\/\/doi.org\/10.3390\/jcm14072211","journal-title":"J Clin Med"},{"key":"6101_CR50","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/ehf2.14457","volume":"11","author":"AA Sherif","year":"2024","unstructured":"Sherif AA, Gilvaz VJ, Abraham S, Saji AM, Mathew D, Isath A, Rajendran A, Contreras J, Lanier GM, Reginato AM (2024) Systemic sclerosis is associated with increased in-patient mortality in patients hospitalized for heart failure. ESC Heart Fail 11:1900\u20131910. https:\/\/doi.org\/10.1002\/ehf2.14457","journal-title":"ESC Heart Fail"},{"key":"6101_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2217\/fca-2020-0238","volume":"18","author":"M Fontes Oliveira","year":"2022","unstructured":"Fontes Oliveira M, Rei AL, Oliveira MI, Almeida I, Santos M (2022) Prevalence and prognostic significance of heart failure with preserved ejection fraction in systemic sclerosis. Future Cardiol 18:17\u201325. https:\/\/doi.org\/10.2217\/fca-2020-0238","journal-title":"Future Cardiol"},{"key":"6101_CR52","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s10554-019-01621-w","volume":"35","author":"A Porp\u00e1czy","year":"2019","unstructured":"Porp\u00e1czy A, N\u00f3gr\u00e1di \u00c1, V\u00e9rtes V, T\u0151k\u00e9s-F\u00fczesi M, Czirj\u00e1k L, Kom\u00f3csi A, Faludi R (2019) Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients. Int J Cardiovasc Imaging 35:1795\u20131802. https:\/\/doi.org\/10.1007\/s10554-019-01621-w","journal-title":"Int J Cardiovasc Imaging"},{"key":"6101_CR53","doi-asserted-by":"publisher","first-page":"152622","DOI":"10.1016\/j.semarthrit.2024.152622","volume":"71","author":"G De Luca","year":"2025","unstructured":"De Luca G, De Santis M, Batani V, Tonutti A, Campochiaro C, Palmisano A, Vignale D, Motta F, Monti L, Francone M, Selmi C, Matucci-Cerinic M, Esposito A, Dagna L (2025) Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: an Italian cardiac magnetic resonance based study. Semin Arthritis Rheum 71:152622. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152622","journal-title":"Semin Arthritis Rheum"},{"key":"6101_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.semarthrit.2020.10.016","volume":"51","author":"L Ross","year":"2021","unstructured":"Ross L, Moxey J, Nikpour M (2021) Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review. Semin Arthritis Rheum 51:299\u2013309. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.10.016","journal-title":"Semin Arthritis Rheum"},{"key":"6101_CR55","doi-asserted-by":"publisher","unstructured":"Gy\u00f6rfi AH, Filla T, Polzin A, Tascilar K, Buch M, Tr\u00f6bs M, Matei AE, Airo P, Balbir-Gurman A, Kuwert F, Mihai C, Kabala A, Gra\u00dfhoff H, Callaghan J, Isomura Y, Mansour J, Spierings J, Tennoe AH, Selvi E, Riccieri V, Hoffmann-Vold AM, Bergmann C, Schett G, Hunzelmann N, van Laar JM, Saketkoo LA, Kuwana M, Siegert E, Riemekasten G, Distler O, du, Four T, Smith V, Truchetet ME, Distler JHW (2025) Evaluation of systemic sclerosis primary heart involvement and chronic heart failure in the European Scleroderma Trials and Research cohort. J Am Heart Assoc 14:e036730. https:\/\/doi.org\/10.1161\/JAHA.124.036730","DOI":"10.1161\/JAHA.124.036730"},{"key":"6101_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/BOR.0000000000000990","volume":"36","author":"G De Luca","year":"2024","unstructured":"De Luca G, Matucci-Cerinic M, Mavrogeni SI (2024) Diagnosis and management of primary heart involvement in systemic sclerosis. Curr Opin Rheumatol 36:76\u201393. https:\/\/doi.org\/10.1097\/BOR.0000000000000990","journal-title":"Curr Opin Rheumatol"},{"key":"6101_CR57","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1007\/s00296-024-05732-z","volume":"44","author":"BA Permenov","year":"2024","unstructured":"Permenov BA, Zimba O, Yessirkepov M, Anartayeva M, Suigenbayev D, Kocyigit BF (2024) Extracorporeal membrane oxygenation: unmet needs and perspectives. Rheumatol Int 44:2745\u20132756. https:\/\/doi.org\/10.1007\/s00296-024-05732-z","journal-title":"Rheumatol Int"},{"key":"6101_CR58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/joim.13595","volume":"293","author":"G Sun","year":"2023","unstructured":"Sun G, Fosb\u00f8l EL, Yafasova A, Faurschou M, Lindhardsen J, Torp-Pedersen C, K\u00f8ber L, Butt JH (2023) Long-term risk of heart failure and other adverse cardiovascular outcomes in primary Sj\u00f6gren\u2019s syndrome. J Intern Med 293:457\u2013469. https:\/\/doi.org\/10.1111\/joim.13595","journal-title":"J Intern Med"},{"key":"6101_CR59","doi-asserted-by":"publisher","first-page":"204062232210780","DOI":"10.1177\/20406223221078083","volume":"13","author":"CY Lin","year":"2022","unstructured":"Lin CY, Chen HA, Chang TW, Hsu TC, Hsu CY, Su YJ (2022) Association of primary Sj\u00f6gren\u2019s syndrome with incident heart failure: a secondary analysis of health claims data in Taiwan. Ther Adv Chronic Dis 13:20406223221078083. https:\/\/doi.org\/10.1177\/20406223221078083","journal-title":"Ther Adv Chronic Dis"},{"key":"6101_CR60","doi-asserted-by":"publisher","first-page":"e42451","DOI":"10.1097\/MD.0000000000042451","volume":"104","author":"J Wu","year":"2025","unstructured":"Wu J, Zhang H, Xie W, Han M, Nie Q (2025) The necessity for prompt identification of Sj\u00f6gren syndrome in instances of unexplained heart failure: a case report. Med (Baltim) 104:e42451. https:\/\/doi.org\/10.1097\/MD.0000000000042451","journal-title":"Med (Baltim)"},{"key":"6101_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3340\/jkns.2018.0110","volume":"62","author":"KH Bae","year":"2019","unstructured":"Bae KH, Hong JB, Choi YJ, Jung JH, Han IB, Choi JM, Sohn S (2019) Association of congestive heart failure and death with ankylosing spondylitis: a nationwide longitudinal cohort study in Korea. J Korean Neurosurg Soc 62:217\u2013224. https:\/\/doi.org\/10.3340\/jkns.2018.0110","journal-title":"J Korean Neurosurg Soc"},{"key":"6101_CR62","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jch.14827","volume":"26","author":"O Bolaji","year":"2024","unstructured":"Bolaji O, Oriaifo O, Adabale O, Dilibe A, Kuruvada K, Ouedraogo F, Ezeh E, Nair A, Olanipekun T, Mazimba S, Alraies C (2024) A meta-analysis of left ventricular dysfunction in ankylosing spondylitis. J Clin Hypertens (Greenwich) 26:772\u2013788. https:\/\/doi.org\/10.1111\/jch.14827","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"6101_CR63","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/postmj\/qgad045","volume":"99","author":"S Eid","year":"2023","unstructured":"Eid S, Sharif K, McGonagle D, Patt YS, Tsur AM, Adawi M, Cohen AD, Amital H, Watad A (2023) Ankylosing spondylitis is associated with increased prevalence of valvular heart diseases: a cross-sectional population-based study. Postgrad Med J 99:1088\u20131093. https:\/\/doi.org\/10.1093\/postmj\/qgad045","journal-title":"Postgrad Med J"},{"key":"6101_CR64","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/ard-2023-225406","volume":"83","author":"JW Kim","year":"2024","unstructured":"Kim JW, Yoon JS, Park S, Kim H, Lee JS, Choe JY (2024) Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis. Ann Rheum Dis 83:1028\u20131033. https:\/\/doi.org\/10.1136\/ard-2023-225406","journal-title":"Ann Rheum Dis"},{"key":"6101_CR65","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5114\/reum\/168362","volume":"61","author":"A Trybuch","year":"2023","unstructured":"Trybuch A, Tarnacka B (2023) Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches. Reumatologia 61:202\u2013212. https:\/\/doi.org\/10.5114\/reum\/168362","journal-title":"Reumatologia"},{"key":"6101_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/art.41907","volume":"74","author":"CY Lin","year":"2022","unstructured":"Lin CY, Chen HA, Hsu TC, Wu CH, Su YJ, Hsu CY (2022) Time-dependent analysis of risk of new-onset heart failure among patients with polymyositis and dermatomyositis. Arthritis Rheumatol 74:140\u2013149. https:\/\/doi.org\/10.1002\/art.41907","journal-title":"Arthritis Rheumatol"},{"key":"6101_CR67","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/joim.13309","volume":"290","author":"A Yafasova","year":"2021","unstructured":"Yafasova A, Diederichsen LP, Schou M, Sun G, Torp-Pedersen C, Gislason GH, Fosb\u00f8l EL, K\u00f8ber L, Butt JH (2021) Increased long-term risk of heart failure and other adverse cardiac outcomes in dermatomyositis and polymyositis: insights from a nationwide cohort. J Intern Med 290:704\u2013714. https:\/\/doi.org\/10.1111\/joim.13309","journal-title":"J Intern Med"},{"key":"6101_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-022-02906-7","volume":"24","author":"A P\u00e9ter","year":"2022","unstructured":"P\u00e9ter A, Balogh \u00c1, Csan\u00e1di Z, Dank\u00f3 K, Griger Z (2022) Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis\/dermatomyositis: a 2-year longitudinal study. Arthritis Res Ther 24:219. https:\/\/doi.org\/10.1186\/s13075-022-02906-7","journal-title":"Arthritis Res Ther"},{"key":"6101_CR69","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3899\/jrheum.140626","volume":"42","author":"A P\u00e9ter","year":"2015","unstructured":"P\u00e9ter A, Balogh \u00c1, Szil\u00e1gyi S, Faludi R, Nagy-Vincze M, \u00c9des I, Dank\u00f3 K (2015) Echocardiographic abnormalities in new-onset polymyositis\/dermatomyositis. J Rheumatol 42:272\u2013281. https:\/\/doi.org\/10.3899\/jrheum.140626","journal-title":"J Rheumatol"},{"key":"6101_CR70","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/mr\/roab041","volume":"32","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang X, Qin L, Luo Q, Wang H (2022) Left ventricle diastolic dysfunction in idiopathic inflammatory myopathies: a meta-analysis and systematic review. Mod Rheumatol 32:589\u2013597. https:\/\/doi.org\/10.1093\/mr\/roab041","journal-title":"Mod Rheumatol"},{"key":"6101_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrcardio.2012.157","volume":"10","author":"K Roberts","year":"2013","unstructured":"Roberts K, Colquhoun S, Steer A, Rem\u00e9nyi B, Carapetis J (2013) Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol 10:49\u201358. https:\/\/doi.org\/10.1038\/nrcardio.2012.157","journal-title":"Nat Rev Cardiol"},{"key":"6101_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5152\/TurkArchPediatr.2024.23162","volume":"59","author":"S Top\u00e7u","year":"2024","unstructured":"Top\u00e7u S, U\u00e7ar T (2024) Echocardiographic screening of rheumatic heart disease: current concepts and challenges. Turk Arch Pediatr 59:3\u201312. https:\/\/doi.org\/10.5152\/TurkArchPediatr.2024.23162","journal-title":"Turk Arch Pediatr"},{"key":"6101_CR73","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1093\/ehjci\/jeac134","volume":"23","author":"S Mavrogeni","year":"2022","unstructured":"Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, Sade LE, Ajmone-Marsan N, Seferovic P, Donal E, Nurmohamed M, Cerinic MM, Sfikakis P, Kitas G, Schwitter J, Lima JAC, Dawson D, Dweck M, Haugaa KH, Keenan N, Moon J, Stankovic I, Donal E, Cosyns B (2022) Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 23:e308\u2013e322. https:\/\/doi.org\/10.1093\/ehjci\/jeac134","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06101-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:53:32Z","timestamp":1781643212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06101-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6101"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06101-8","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"67"}}